Responsible Marketing
Supporting the SDGs Goals
Stakeholders Directly Impacted
Goals and Performance Highlights
Commitment, Challenge and Opportunity
Since the products of the group are related to user health, in addition to producing quality, safe, and standardized products, providing accurate information about the products is considered a high priority responsibility. The group will not provide false, misleading, exaggerated advertisements or use messaging, audio, or images that mislead customers about gender, religion, race, disabilities, or personal relationships that could cause confusion about the quality, quantity, price, or reference products of other manufacturers.
Management and Operational Approach
The group has studied the legal requirements for advertising both online and offline, and regularly trains employees on these laws every month. The group also reviews product information for pharmacy customers, hospitals, and consumers to ensure correct product usage and addresses complaints regarding product quality.
The group provides useful product information tailored to customer needs and behavior to assist in decision-making through marketing activities, and does not engage in deceptive practices or promote false information about products. Advertising materials, including labels for pharmaceuticals, herbal products, dietary supplements, and medical devices, are distributed to the public with correct details. The group also promotes product knowledge and manufacturing standards for all employees through internal or external projects or activities.
The group’s communication and public relations efforts control the dissemination of media and advertising strictly, adhering primarily to the regulations set by the Food and Drug Administration (FDA)
In cases where third parties, such as customers, use media for advertising, which the group cannot control, if such actions are found, the company has measures in place to educate customers. The company does not encourage or hire customers to engage in exaggerated advertising. Before customers distribute products, the group informs them about advertising guidelines, specifying that only media prepared by the company should be used, as it has been authorized by the FDA. For products that do not require FDA approval for advertising, the company carefully screens the content and advertising media before delivering them to customers, ensuring they comply with relevant standards and regulations
In marketing and public relations, the Group conducts regular monthly training for its sales personnel, focusing on product knowledge and ensuring that information regarding the pharmaceutical industry remains up to date. This helps enhance the sales team’s expertise in delivering accurate and timely information to pharmacy and hospital customers, thereby improving the overall quality of product-related communication.
The group places high importance on conducting business ethically and transparently, particularly in the sale of medicines and medical products, which directly impact consumers’ health. The group is committed to strictly following ethical standards and relevant laws. Our company is a member of the Thai Pharmaceutical Manufacturers Association (TPMA), which oversees ethical practices in drug promotion in Thailand. The association plays a crucial role in setting practices and regulations aligned with international standards to ensure that our employees have accurate knowledge and understanding of the Pharmaceutical Sale Act and related laws and regulations. The company participates in training programs organized by the TPMA, covering topics such as:
Employees who participate in training must pass tests based on the association’s standards and will receive a certificate as evidence of their readiness and ability to operate in accordance with ethical principles.
In addition to employee training, our company also promotes a corporate culture focused on honesty and business ethics through the following actions:
- Internal meetings to review ethical principles and required standards
- Appointing representatives from the company, trained by the association, to transmit knowledge and practices to employees within the organization
The company is committed to continuously monitoring and evaluating ethical practices in drug sales, tracking employee exam results, and providing further guidance when necessary to ensure that our company can maintain ethical standards and credibility in the pharmaceutical industry sustainably.
In 2025, the Company received notification from the Ratchaburi Provincial Public Health Office regarding advertising for cosmetic products marketed under the customer’s brand (outsourced OEM production), which potentially exceeded the legal limits for permitted claims. The Company does not own the brand. However, it coordinated with relevant agencies to revise the product label based on official recommendations and has continued to monitor the implementation of these changes. This demonstrates the Company’s commitment to responsible business practices, cooperation with regulatory bodies, and consumer protection.
The Group emphasizes communication quality, including ensuring labels and advertising materials meet legal standards, offering channels for complaints and product inquiries, and taking a proactive approach such as educating stakeholders to mitigate potential issues with regulatory bodies.
However, the working group has held regular monthly meetings to monitor progress, evaluate results, and make improvements, ensuring operations align with the current context and can adapt to future changes.
